New Key Statistics Module, Z-Score and F-Score
NAS:MIRM Key Ratios
| Market Cap $ M | 2,024.35 |
| Enterprise Value $ M | 2,057.56 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 8.72 |
| Price/Sales | 6.48 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 307.00 |
| EPS (TTM) $ | -2.07 |
| Beneish M-Score | -2.36 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -24.33 |
| EV-to-EBITDA | -33.59 |
| PEG | -- |
| Shares Outstanding M | 48.00 |
| Net Margin (%) | -32.51 |
| Operating Margin % | -31.26 |
| Pre-tax Margin (%) | -31.91 |
| Quick Ratio | 3.15 |
| Current Ratio | 3.34 |
| ROA % (ttm) | -15.22 |
| ROE % (ttm) | -41.13 |
| ROIC % (ttm) | -33.22 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.02 |
MIRM Number of Guru Trades
MIRM Volume of Guru Trades
Gurus Latest Trades with NAS:MIRM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MIRM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Mirum Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:MIRM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers